TransDigm Group is set to acquire Raptor Scientific for $655 million in cash. Raptor Scientific, owned by L Squared Capital Partners, specializes in complex test and measurement solutions for aerospace and defense, generating nearly all revenue from proprietary products.
Corcept Therapeutics announced the GRACE Phase 3 trial results for relacorilant in Cushing's syndrome, showing significant improvements in hypertension and hyperglycemia.
Bank of Nova Scotia reported Q2 revenue growth of 5.5%, with net income declining and CET1 capital ratio increasing. Operating leverage was achieved through revenue growth and expense discipline.